FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves a supplemental application for Cilostazol submitted by Apotex Corp., updating the drug's approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)